Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.4M Sell
89,268
-6,611
-7% -$2.36M 0.21% 90
2025
Q4
$31.4M Sell
95,879
-260
-0.3% -$82.5K 0.19% 94
2025
Q3
$27.1M Buy
96,139
+6,911
+8% +$2M 0.17% 108
2025
Q2
$24.9M Sell
89,228
-556
-0.6% -$158K 0.17% 104
2025
Q1
$28M Buy
89,784
+986
+1% +$291K 0.21% 100
2024
Q4
$23.1M Buy
88,798
+8,494
+11% +$2.52M 0.17% 100
2024
Q3
$25.9M Buy
80,304
+382
+0.5% +$125K 0.19% 95
2024
Q2
$25M Buy
79,922
+13,391
+20% +$3.93M 0.21% 82
2024
Q1
$18.9M Buy
66,531
+6,574
+11% +$1.92M 0.18% 99
2023
Q4
$17.3M Sell
59,957
-3,955
-6% -$1.08M 0.19% 100
2023
Q3
$17.2M Sell
63,912
-25,725
-29% -$6.42M 0.21% 96
2023
Q2
$19.9M Buy
+89,637
New +$20.8M 0.23% 93

Other funds holding AMGN

UniSuper Management's AMGN Position: Q1 2026 in Review

UniSuper Management reduced its Amgen (AMGN) stake by 6.9% in Q1 2026, selling an estimated $2.36M and leaving 89,268 shares worth $31.4M. The position accounts for 0.21% of the portfolio, ranked #90.

UniSuper Management first reported a position in AMGN in Q2 2023 and has held it in 12 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • UniSuper Management held 89,268 shares of Amgen worth $31.4M as of Q1 2026.
  • UniSuper Management sold 6,611 Amgen shares in Q1 2026, an estimated $2.36M.
  • Amgen made up 0.21% of UniSuper Management's portfolio in Q1 2026, its #90 holding.
  • UniSuper Management first reported a position in Amgen in Q2 2023 and has held it in 12 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on UniSuper Management's 13F filing for Q1 2026, filed 11 May 2026.